Phase 1 Metastatic Adenocarcinoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Metastatic Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma+1 more

Mayo Clinic40 enrolled1 locationNCT04605913

Recruiting

Phase 1

A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Metastatic Adenocarcinoma of the Pancreas

Boryung Pharmaceutical Co., Ltd20 enrolled2 locationsNCT06867497

Recruiting

Phase 1Phase 2

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmAdvanced Malignant Solid Neoplasm+3 more

Tianhong Li77 enrolled1 locationNCT05101356